Investing Ideas
/
U.K. Pharmaceuticals & Biotech High Insider Buying

U.K. Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

12 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
AZN AstraZeneca	UK£102.56	-2.0%	-1.7%	UK£159.0b	UK£139.39	PE30.8x	E18.2%	2.3%
GSK GSK	UK£13.20	-0.7%	-8.9%	UK£53.9b	UK£18.17	PE21.5x	E23.2%	4.4%
BVXP Bioventix	UK£33.25	-5.0%	-22.7%	UK£173.6m	UK£51.00	PE21.4x	n/a	4.7%
REDX Redx Pharma	UK£0.15	62.2%	-53.8%	UK£58.3m	UK£1.30	PS13.9x	E-22.3%	n/a
EAH ECO Animal Health Group	UK£0.71	2.9%	-35.7%	UK£48.1m	UK£1.60	PE73.1x	E39.2%	0%
C4XD C4X Discovery Holdings	UK£0.12	45.9%	-16.4%	UK£30.3m	UK£0.48	PE2.9x	E-88.3%	n/a
ONC Oncimmune Holdings	UK£0.15	-4.8%	-41.6%	UK£16.7m	UK£0.50	PS13.7x	E100.9%	n/a
APTA Aptamer Group	UK£0.0035	-9.1%	-70.2%	UK£6.7m	n/a	PS7.8x	n/a	n/a
FAB Fusion Antibodies	UK£0.067	3.9%	57.6%	UK£6.4m	n/a	PS3.6x	n/a	n/a
OBD Oxford BioDynamics	UK£0.012	-2.3%	-96.0%	UK£3.7m	n/a	PS6x	E-4.5%	n/a
PYC Physiomics	UK£0.0075	-6.3%	-53.1%	UK£1.5m	n/a	PS2.7x	n/a	n/a
NFX Nuformix	UK£0.0005	-4.8%	-82.1%	UK£409.7k	n/a	PB0.1x	n/a	n/a

Page 1 of 1